Patient Evaluation for Head and Neck Surgery Branch Studies
NCT00011492 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 62
Last updated 2020-11-27
Summary
This purpose of this protocol is to evaluate and identify patients who may be eligible for actively enrolling NIH clinical research protocols for head and neck cancer; or provide standard evaluations and treatment necessary for patients with head and neck cancers enrolled in other NIH clinical protocols that do not include such treatment. Participants screened under this protocol will not be required to join a research study; the decision will be voluntary.
Patients with head and neck cancer may enroll in this study. Participants may undergo various tests, described below, to determine their eligibility for participation in a specific clinical trial. Other tests may also be required, depending on the protocol or treatment for which the patient is being considered:
* Blood tests About 3 to 5 tablespoons of blood will be drawn for routine tests, HLA typing and hepatitis and HIV screening.
* Magnetic resonance imaging (MRI) This imaging procedure uses a powerful magnetic field to produce pictures of parts of the body in small section views. The test does not use radiation and may be done with or without a contrast dye material.
* Computerized tomography (CT) This procedure uses x-rays to produces three-dimensional images of body organs in small section views. A contrast dye may or may not be used.
* Positron emission tomography (PET) PET scans allow the doctor to see the activity of cells in specific body tissues. It requires injection of a radioactive material that attaches to a sugar fluid. The fluid goes to very active cells, such as cancer cells, revealing tumors.
* Pulmonary function tests These tests use a machine the patient breathes into to measure the volume of air the patient can move in and out of the lungs.
* Arteriogram, or angiogram The anatomy of the blood vessels can be seen using this procedure, which involves placing a small catheter (plastic tube) into an artery and injecting a contrast solution. Special X-rays are then taken to show the blood vessels.
* Endoscopy This procedure is done to evaluate the mouth and throat. A tube with a light on the end and special fibers is inserted down the throat to allow the surgeon to examine the throat and, if needed, biopsy a piece of tissue for microscopic study. The test is usually done under general anesthesia in the operating room.
* Biopsy A piece of tissue or tumor is removed for examination under the microscope. When a biopsy is done in the neck area, a small amount of anesthetic is injected into the area of the biopsy. The biopsy may be done with 1) a small needle to pull out some tissue, 2) a cookie-cutter-like instrument to punch out a small piece of tissue, or 3) a small knife to cut out a piece of tissue. A knife biopsy may be done in the operating room or the clinic depending on the location of the biopsy and precautions required.
When the tests are done, the physician will discuss the results with the patient. Patients eligible for a research study will be offered participation. For those not eligible for a study, other therapies will be discussed and the patient will return to the care of his or her primary physician. In special circumstances, patients may be offered standard non-experimental treatment at NIH.
Conditions
- Head and Neck Neoplasms
- Pharyngeal Cancer
- Oral Cancer
- Carcinoma, Squamous Cell
- Laryngeal Cancer
Sponsors & Collaborators
-
National Institute on Deafness and Other Communication Disorders (NIDCD)
lead NIH
Principal Investigators
-
Carter Van Waes, M.D. · National Institute on Deafness and Other Communication Disorders (NIDCD)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-03-12
- Primary Completion
- 2020-11-23
- Completion
- 2020-11-23
Countries
- United States
Study Locations
More Related Trials
-
Evaluating the Use of an Informational Head and Neck Cancer Website.
NCT04268329 ·Status: TERMINATED ·Phase: NA
-
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
NCT05544136 ·Status: RECRUITING ·Phase: PHASE2
-
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma
NCT03422536 ·Status: COMPLETED ·Phase: PHASE2
-
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00020189 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer
NCT02764593 ·Status: COMPLETED ·Phase: PHASE1
-
Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
NCT00002932 ·Status: COMPLETED ·Phase: PHASE2
-
A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC
NCT00483821 ·Status: COMPLETED
-
Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
NCT06662058 ·Status: RECRUITING ·Phase: NA
-
The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell Carcinoma
NCT02916368 ·Status: UNKNOWN
-
Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer
NCT06005324 ·Status: RECRUITING ·Phase: PHASE1
-
Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and Neck
NCT01952821 ·Status: COMPLETED
-
De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
NCT03952585 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
NCT00911326 ·Status: TERMINATED ·Phase: PHASE3
-
Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer
NCT03894891 ·Status: COMPLETED ·Phase: PHASE2
-
Individualized Follow-Up for Head and Neck Cancer
NCT05386225 ·Status: RECRUITING
-
Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer
NCT00021424 ·Status: COMPLETED ·Phase: PHASE1
-
Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer
NCT02262221 ·Status: SUSPENDED ·Phase: NA
-
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer
NCT03247712 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)
NCT04938609 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based Therapy
NCT03114163 ·Status: COMPLETED
-
Nasopharyngeal Carcinoma Post IMRT
NCT02597426 ·Status: ACTIVE_NOT_RECRUITING
-
Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00423930 ·Status: COMPLETED ·Phase: PHASE2
-
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
NCT07195734 ·Status: RECRUITING ·Phase: PHASE2
-
Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
NCT06380686 ·Status: RECRUITING
-
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
NCT00544414 ·Status: COMPLETED ·Phase: PHASE2